G
G. Pokorny
Researcher at University of Szeged
Publications - 26
Citations - 2227
G. Pokorny is an academic researcher from University of Szeged. The author has contributed to research in topics: Lupus erythematosus & Lupus nephritis. The author has an hindex of 18, co-authored 26 publications receiving 2028 citations.
Papers
More filters
Journal ArticleDOI
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Gerald B. Appel,Gabriel Contreras,Mary Anne Dooley,Ellen M. Ginzler,David A. Isenberg,David Jayne,Lei Shi Li,Eduardo Mysler,Jorge Sánchez-Guerrero,Neil Solomons,David Wofsy,Carlos Abud,Sharon G. Adler,Graciela S. Alarcón,Elisa N. Albuquerque,Fernando Almeida,Alejandro Alvarellos,Gerald B. Appel,Hilario Avila,Cornelia Blume,Ioannis Boletis,Alain Bonnardeaux,Alan Braun,Jill P. Buyon,Ricard Cervera,Nan Chen,Shun-Le Chen,António Gomes Da Costa,Razeen Davids,David D'Cruz,Enrique de Ramón,Atul Deodhar,Andrea Doria,Bertrand Dussol,Paul Emery,Justus Fiechtner,Jürgen Floege,Hilda Fragoso-Loyo,Richard Furie,Rozina Ghazalli,Cybele Ghossein,Gary S. Gilkeson,EM Ginzler,Caroline Gordon,Jennifer M. Grossman,Jieruo Gu,Loïc Guillevin,Pierre Yves Hatron,Gisela Herrera,Falk Hiepe,Frédéric Houssiau,Osvaldo Hübscher,Claudia Hura,Joshua Kaplan,Gianna Mastroianni Kirsztajn,Emese Kiss,Ghazali Ahmad Kutty,Maurice Laville,Maria Lazaro,Oliver Lenz,Leishi Li,Liz Lightstone,Sam Lim,Michel Malaise,Susan Manzi,Juan Carlos Marcos,Olivier Meyer,Pablo Monge,Saraladev Naicker,Nathaniel Neal,Michael Neuwelt,Kathy Nicholls,Nancy J. Olsen,José Ordi-Ros,Barbara E. Ostrov,Manuel Pestana,Michelle Petri,G. Pokorny,Jacques Pourrat,Jiaqi Qian,Jai Radhakrishnan,Brad H. Rovin,Julio Sanchez Roman,Joseph C. Shanahan,William Shergy,Fotini Skopouli,Alberto Spindler,Christopher Striebich,Robert Sundel,Charles R. Swanepoel,Yen Tan Si,Guillermo Tate,Vladimír Tesaŕ,Mohamed Tikly,Haiyan Wang,Rosnawati Yahya,Xueqing Yu,Fengchun Zhang,Diana Zoruba +98 more
TL;DR: Although most patients in both treatment groups experienced clinical improvement, the study did not meet its primary objective of showing that MMF was superior to IVC as induction treatment for lupus nephritis.
Journal ArticleDOI
Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrual.
Johannes C. Nossent,Nada Čikeš,Emese Kiss,Antonio Marchesoni,V. Nassonova,Marta Mosca,Marzena Olesińska,G. Pokorny,Blaž Rozman,Matthias Schneider,Panayiotis G. Vlachoyiannopoulos,A. J. G. Swaak +11 more
TL;DR: The bimodal mortality curve has flattened out and deaths now occur evenly throughout the disease course with infectious and cardiovascular complications as the main direct COD in both early and late fatalities.
Journal ArticleDOI
Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus.
Johannes C. Nossent,Emese Kiss,Blaž Rozman,G. Pokorny,Panayiotis G. Vlachoyiannopoulos,Marzena Olesińska,Antonio Marchesoni,Marta Mosca,S Påi,K. Manger,Matthias Schneider,Henrik Nielsen,R. van Vollenhoven,Tom J.G. Swaak +13 more
TL;DR: Despite early reductions in disease activity and improved mortality, the risk for disease flare and damage development is, however, still substantial, especially in patients not entering an early remission.
Journal ArticleDOI
The place of magnetic resonance and ultrasonographic examinations of the parotid gland in the diagnosis and follow-up of primary Sjögren's syndrome
Éva Makula,G. Pokorny,Mária Kiss,Erika Vörös,László Kovács,Attila Kovács,László Csernay,András Palkó +7 more
TL;DR: MRI appears unnecessary as a routine method in the diagnosis of SS; US examination is suitable both for the diagnosis and follow-up of SS.
Journal ArticleDOI
Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT)
A. J. G. Swaak,H. van de Brink,R. J. T. Smeenk,K. Manger,J. R. Kalden,S. Tosi,Antonio Marchesoni,Z. Domljan,Blaž Rozman,D. Logar,G. Pokorny,László Kovács,Attila Kovács,P. G. Vlachoyiannopoulos,H. M. Moutsopoulos,H. Chwalinska-Sadowska,B. Dratwianka,Emese Kiss,Nada Čikeš,Branimir Anić,Matthias Schneider,R. Fischer,Stefano Bombardieri,Marta Mosca,Winfried Graninger,J. S. Smolen +25 more
TL;DR: A high proportion of patients defined on clinical grounds as having incomplete SLE eventually showed disease activity defined by the SLEDAI as well as ECLAM, which suggests that incomplete Sle forms a subgroup of SLE that has a good prognosis.